Global Health Alerts: Mpox, Polio, and New Diagnostic Advances

Recent health briefs highlight Bavarian Nordic's application to extend its mpox vaccine to adolescents and the FDA's approval of the first at-home syphilis test. The WHO has declared mpox a public health emergency again, while polio has been detected in Gaza. Efforts to ensure equitable access to mpox vaccines and raise awareness of the Oropouche virus in the Americas are underway.

Recent health news underscores significant developments in global public health. Bavarian Nordic has submitted data to the EU seeking approval to extend the use of its mpox and smallpox vaccine to adolescents aged 12 to 17. The WHO has declared mpox a global emergency again, citing increased vulnerability among children and teenagers.

In another important development, the FDA has authorized the marketing of the first at-home test for syphilis, designed to detect antibodies in human blood within 15 minutes. Developed by NOWDiagnostics, this test could significantly improve screening rates for the sexually transmitted disease.

Additionally, the Palestinian health ministry has reported the first case of polio in Gaza, affecting a 10-month-old baby. These updates underline the ongoing challenges and efforts to curb infectious diseases globally.